Evidence map›Paper›PMID 31332003›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Deep learning of spontaneous arousal fluctuations detects early cholinergic defects across neurodevelopmental mouse models and patients.

Pietro Artoni, Arianna Piffer, Viviana Vinci, Jocelyn LeBlanc, Charles A Nelson, Takao K Hensch, Michela Fagiolini

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Pietro ArtoniF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115.
Arianna PifferF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115.
Viviana VinciF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115.
Jocelyn LeBlancF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115.
Charles A NelsonDivision of Developmental Medicine, Boston Children's Hospital, Boston, MA 02115.
Takao K HenschF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115.
Michela FagioliniF. M. Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Boston, MA 02115; michela.fagiolini@childrens.harvard.edu.
Boston Children's Hospital · USHarvard University · USThe University of Tokyo · JP

Funding

Res Support CoreP50MH094271 · NIMH · HARVARD UNIVERSITY · PI HENSCH, TAKAO K · 2011 to 2022
$18.6M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Visual Circuit Regression and its Rescue in RTT Mouse ModelsR01NS095959 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI CHEN, CHINFEI, FAGIOLINI, MICHELA · 2015 to 2018
$2.3M
NICHD NIH HHS U54 HD090255NIMH NIH HHS P50 MH094271NINDS NIH HHS R01 NS095959
6 · The paper itself

Abstract

Neurodevelopmental spectrum disorders like autism (ASD) are diagnosed, on average, beyond age 4 y, after multiple critical periods of brain development close and behavioral intervention becomes less effective. This raises the urgent need for quantitative, noninvasive, and translational biomarkers for their early detection and tracking. We found that both idiopathic (BTBR) and genetic (CDKL5- and MeCP2-deficient) mouse models of ASD display an early, impaired cholinergic neuromodulation as reflected in altered spontaneous pupil fluctuations. Abnormalities were already present before the onset of symptoms and were rescued by the selective expression of MeCP2 in cholinergic circuits. Hence, we trained a neural network (ConvNetACh) to recognize, with 97% accuracy, patterns of these arousal fluctuations in mice with enhanced cholinergic sensitivity (LYNX1-deficient). ConvNetACh then successfully detected impairments in all ASD mouse models tested except in MeCP2-rescued mice. By retraining only the last layers of ConvNetACh with heart rate variation data (a similar proxy of arousal) directly from Rett syndrome patients, we generated ConvNetPatients, a neural network capable of distinguishing them from typically developing subjects. Even with small cohorts of rare patients, our approach exhibited significant accuracy before (80% in the first and second year of life) and into regression (88% in stage III patients). Thus, transfer learning across species and modalities establishes spontaneous arousal fluctuations combined with deep learning as a robust noninvasive, quantitative, and sensitive translational biomarker for the rapid and early detection of neurodevelopmental disorders before major symptom onset.

Indexed as

ArousalDeep LearningAcetylcholineAnimalsAutistic DisorderCohort StudiesDisease Models, AnimalFemaleHumansMaleMethyl-CpG-Binding Protein 2MiceProtein Serine-Threonine KinasesPupilRett SyndromeAcetylcholineCDKL5 protein, mouseMecp2 protein, mouseMethyl-CpG-Binding Protein 2Protein Serine-Threonine KinasesCDKL5 disorderLYNX1MECP2Rett syndrometransfer learning

Identifiers

PMID31332003
PMCPMC7519255
OpenAlexW2963647538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.